Cargando…

Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis

PURPOSE: Radiation therapy (RT) induces an immune response, but the relationship of this response with tumor type is not fully understood. This meta-analysis further elucidated this relationship by analyzing the changes in T lymphocyte subsets in different tumors before and after radiotherapy. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qin, Li, Shangbiao, Qiao, Simiao, Zheng, Zhihao, Duan, Xiaotong, Zhu, Xiaoxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242248/
https://www.ncbi.nlm.nih.gov/pubmed/34220806
http://dx.doi.org/10.3389/fimmu.2021.648652
_version_ 1783715592967028736
author Wang, Qin
Li, Shangbiao
Qiao, Simiao
Zheng, Zhihao
Duan, Xiaotong
Zhu, Xiaoxia
author_facet Wang, Qin
Li, Shangbiao
Qiao, Simiao
Zheng, Zhihao
Duan, Xiaotong
Zhu, Xiaoxia
author_sort Wang, Qin
collection PubMed
description PURPOSE: Radiation therapy (RT) induces an immune response, but the relationship of this response with tumor type is not fully understood. This meta-analysis further elucidated this relationship by analyzing the changes in T lymphocyte subsets in different tumors before and after radiotherapy. METHODS: We searched English-language electronic databases including PubMed, EMBASE, and the Cochrane Library to collect studies on the changes in peripheral blood CD3+ T lymphocytes, CD4+ T lymphocytes, and CD8+ T lymphocytes before and after radiotherapy in tumor patients from January 2015 to April 2021. The quality of the included literature was evaluated using the NOS scale provided by the Cochrane Collaboration, and statistical software RevMan 5.4 was used to analyze the included literature. P<0.05 was considered to indicate statistical significance. RESULTS: A total of 19 studies in 16 articles involving 877 tumor patients were included. All data were collected within 1 month before or after radiotherapy. Meta-analysis showed that numbers of CD3+ T lymphocytes (SMD: -0.40; 95% CI [-0.75, -0.04]; p = 0.03) and CD4+ T lymphocytes (SMD: -0.43; 95% CI: [-0.85, -0.02]; p = 0.04) were significantly reduced after radiotherapy compared with before treatment, but there was no statistically significant difference for CD8+ T lymphocytes (SMD: 0.33; 95% CI: [-0.88, 0.74]; p = 0.12). Subgroup analysis showed that peripheral blood T lymphocytes decreased in head and neck cancer. However, in prostate cancer and breast cancer, there was no significant change in peripheral blood. 1 month after radiotherapy, it has a potential proliferation and activation effect on lymphocytes in esophageal cancer and lung cancer. The results showed that CD8+T lymphocytes increased in peripheral blood after SBRT. Radiotherapy alone reduced CD3+ T lymphocyte numbers. CONCLUSIONS: Within 1 month of radiotherapy, patients have obvious immunological changes, which can cause apoptosis and reduction of T lymphocytes, and affect the balance of peripheral blood immune cells. The degree of immune response induced by radiotherapy differed between tumor types.
format Online
Article
Text
id pubmed-8242248
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82422482021-07-01 Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis Wang, Qin Li, Shangbiao Qiao, Simiao Zheng, Zhihao Duan, Xiaotong Zhu, Xiaoxia Front Immunol Immunology PURPOSE: Radiation therapy (RT) induces an immune response, but the relationship of this response with tumor type is not fully understood. This meta-analysis further elucidated this relationship by analyzing the changes in T lymphocyte subsets in different tumors before and after radiotherapy. METHODS: We searched English-language electronic databases including PubMed, EMBASE, and the Cochrane Library to collect studies on the changes in peripheral blood CD3+ T lymphocytes, CD4+ T lymphocytes, and CD8+ T lymphocytes before and after radiotherapy in tumor patients from January 2015 to April 2021. The quality of the included literature was evaluated using the NOS scale provided by the Cochrane Collaboration, and statistical software RevMan 5.4 was used to analyze the included literature. P<0.05 was considered to indicate statistical significance. RESULTS: A total of 19 studies in 16 articles involving 877 tumor patients were included. All data were collected within 1 month before or after radiotherapy. Meta-analysis showed that numbers of CD3+ T lymphocytes (SMD: -0.40; 95% CI [-0.75, -0.04]; p = 0.03) and CD4+ T lymphocytes (SMD: -0.43; 95% CI: [-0.85, -0.02]; p = 0.04) were significantly reduced after radiotherapy compared with before treatment, but there was no statistically significant difference for CD8+ T lymphocytes (SMD: 0.33; 95% CI: [-0.88, 0.74]; p = 0.12). Subgroup analysis showed that peripheral blood T lymphocytes decreased in head and neck cancer. However, in prostate cancer and breast cancer, there was no significant change in peripheral blood. 1 month after radiotherapy, it has a potential proliferation and activation effect on lymphocytes in esophageal cancer and lung cancer. The results showed that CD8+T lymphocytes increased in peripheral blood after SBRT. Radiotherapy alone reduced CD3+ T lymphocyte numbers. CONCLUSIONS: Within 1 month of radiotherapy, patients have obvious immunological changes, which can cause apoptosis and reduction of T lymphocytes, and affect the balance of peripheral blood immune cells. The degree of immune response induced by radiotherapy differed between tumor types. Frontiers Media S.A. 2021-06-16 /pmc/articles/PMC8242248/ /pubmed/34220806 http://dx.doi.org/10.3389/fimmu.2021.648652 Text en Copyright © 2021 Wang, Li, Qiao, Zheng, Duan and Zhu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Wang, Qin
Li, Shangbiao
Qiao, Simiao
Zheng, Zhihao
Duan, Xiaotong
Zhu, Xiaoxia
Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title_full Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title_fullStr Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title_full_unstemmed Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title_short Changes in T Lymphocyte Subsets in Different Tumors Before and After Radiotherapy: A Meta-analysis
title_sort changes in t lymphocyte subsets in different tumors before and after radiotherapy: a meta-analysis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242248/
https://www.ncbi.nlm.nih.gov/pubmed/34220806
http://dx.doi.org/10.3389/fimmu.2021.648652
work_keys_str_mv AT wangqin changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis
AT lishangbiao changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis
AT qiaosimiao changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis
AT zhengzhihao changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis
AT duanxiaotong changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis
AT zhuxiaoxia changesintlymphocytesubsetsindifferenttumorsbeforeandafterradiotherapyametaanalysis